Wachovia Downgrades BioMed Realty Trust (BMR) to Market Perform
Tweet Send to a Friend
Wachovia downgrades BioMed Realty Trust (NYSE: BMR) from Outperform to Market Perform with a $26-$29 valuation range.
This article: 164 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 164 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE